Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
GT Biopharma, Inc. (GTBP) had Return on Tangible Equity of -37.37% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.37M |
|
-- |
|
-- |
|
$2.85M |
|
$-2.85M |
|
$0.01M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.85M |
|
$-2.85M |
|
30.28M |
|
30.28M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$10.00M |
|
-- |
|
-- |
|
$10.00M |
|
$2.42M |
|
-- |
|
-- |
|
$2.42M |
|
$7.58M |
|
$7.58M |
|
$7.58M |
|
35.18M |
|
| Cash Flow Statement Financials | |
$-2.47M |
|
-- |
|
$4.58M |
|
$6.91M |
|
$9.02M |
|
$2.11M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-37.38% |
|
|
Return on Tangible Equity |
-37.37% |
-28.34% |
|
-37.37% |
|
$0.22 |
|
$-0.08 |
|
$-0.08 |
|